Welcome Back to The Respiratory Report – 3rd Edition
In this summary, we highlight the latest issue of our pulmonology research quarterly newsletter powered by the American Lung Association Research Institute.
Related Articles
Fibromyalgia | Medical News & Expert Insight | HCPLive
The fibromyalgia condition center is a comprehensive resource for clinical news and expert insights on fibromyalgia. Read more at HCPLive.
Anemia Exacerbates Adverse Effects of Hypertension and Blood Urea Nitrogen
Anemia can moderate the association between both conditions, increasing the risk of atherosclerotic cardiovascular disease.
FDA Updates Mavacamten Label in Obstructive Hypertrophic Cardiomyopathy
Label updates simplify twice-yearly echo monitoring for eligible patients in the maintenance phase and expand eligibility with reduced contraindications.
Sibeprenlimab’s Potential in IgA Nephropathy, with John Kraus, MD, PhD
Kraus explains current unmet needs in IgA nephropathy and what sibeprenlimab may offer based on the phase 3 VISIONARY study.
FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria
Dupilumab’s approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying…
Viaskin Patch Effective in Peanut-Allergic Kids with Atopic Comorbidities
A phase 3 trial found the Viaskin peanut patch effective in desensitizing peanut-allergic children aged 1 – 3 years, regardless of asthma, atopic dermatitis, or…
Study Finds Costs of Biologic Drugs for Psoriasis Rose Between 2007 to 2021
This analysis pointed to increased costs of biologics given the initiation of newer IL-17 and IL-23 inhibitors, suggesting the use of lower-cost options.
Spring Allergy Tips Clinicians Can Share with Patients, with Noah Greenspan, DPT, PT
Greenspan offers tips in treating seasonal allergies in patients with pulmonary conditions, such as long-COVID, and provides his 2025 spring allergy prediction.
Alopecia
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.